Prospector Partners’s Bioventus BVS Stock Holding History

Prospector Partners’s Portfolio BVS Stock Details BVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-124,355	Closed	-$2.19M	–	111
2021 Q2	$2.19M	Buy	+124,355	New	+$2M	0.28%	77

Other funds holding BVS

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JIC

Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return

Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Prospector Partners's BVS Position: Q3 2021 in Review

Prospector Partners sold out of Bioventus (BVS) in Q3 2021, closing a stake of 124,355 shares — an estimated $2.19M sold.

Prospector Partners first reported a position in BVS in Q2 2021 and held it in 1 quarter. The position peaked at $2.19M in Q2 2021. 69 funds tracked by Wall St. Rank hold BVS as of Q3 2021.

Prospector Partners reported no remaining Bioventus position as of Q3 2021 after selling out during the quarter.
Prospector Partners sold 124,355 Bioventus shares in Q3 2021, an estimated $2.19M.
Prospector Partners first reported a position in Bioventus in Q2 2021 and held it in 1 quarter.
Prospector Partners's Bioventus position peaked at $2.19M in Q2 2021.
69 funds tracked by Wall St. Rank held Bioventus as of Q3 2021.

Based on Prospector Partners's 13F filing for Q3 2021, filed 10 Nov 2021.